FDA Issues Recall On Clinical Specialties Products Due To Contamination Risks

March 22nd, 2013 | Drug injury

March 22, 2013 The U.S. Food and Drug Administration (FDA) has partnered with drug manufacturer, Clinical Specialties, in voluntarily recalling doses of several medications that were packaged by the company and are potentially contaminated. On Monday, the agency issued a press release that announced the recall of more than 40 lots of the drug Avastin® that had been repackaged… Read More

FDA And Drug Manufacturer Issue Recall Due To Contamination

January 11th, 2013 | Drug injury

January 11, 2013 The U.S. Food and Drug Administration (FDA) announced earlier this week that it had partnered with Mobius Therapeutics, LLC, in issuing a voluntary market recall of the company’s Mitosol® (mitomycin for solution), 0.2 mg/vial, kit for ophthalmic use. According to a press release from the agency, the recall was issued due to a possible… Read More